In addition, high NSDHL expression was correlated with reduced survival in cholangiocarcinoma patients in the GEPIA database (Fig. 1D), emphasizing its potential role in the progression of cholangiocarcinoma. This evidence concerns the gene NSDHL and cholangiocarcinoma.